Open
SectorHealthcare
9.12 -1.3
24h
Min
8.67
Max
9.32
Income | 9.3M -85M |
---|---|
Sales | 12M 20M |
EPS | -0.985 |
Profit margin | -423.341 |
Employees | 270 |
EBITDA | 5.6M -84M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +272.36% upside |
Next Earnings | 31 Jul 2025 |
---|
Market Cap | -366M 816M |
---|---|
Previous open | 10.42 |
Previous close | 9.12 |
By Acuity
19%
81%
40 / 380 Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 33.14 USD 272.36%
High 45 USD
Low 17 USD
Based on 8 Wall Street analysts offering 12 month price targets forSyndax Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$